Intersect Capital LLC historic quarter change: Foreign ADRs, Reduced
In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 7 quarters from 2014-12-31 to 2016-09-30, Intersect Capital LLC opened 2 positions, added to 3, reduced 7 and sold out of 9.
- Q4 2015: Stock Royal Dutch Shell B Adrf; Country of operation —; Class SPON ADR B; Shares before 4,950.
- Q4 2015: Stock Glaxosmithkline Plc Adrf; Country of operation —; Class SPONSORED ADR; Shares before 6,941.
- Q3 2015: Stock Glaxosmithkline Plc Adrf; Country of operation —; Class SPONSORED ADR; Shares before 7,941.
- Q2 2015: Stock Royal Dutch Shell B Adrf; Country of operation —; Class SPON ADR B; Shares before 5,230.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1633861), 7 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-10-27); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-09); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-05); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-01); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-03); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-03); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-11). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-12-31.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||